PÁCAL, Lukáš, Veronika TANHÄUSEROVÁ, Jan SVOJANOVSKÝ, Darja KRUSOVÁ, Soňa ŠTĚPÁNKOVÁ, Jindřich OLŠOVSKÝ, Jana BĚLOBRÁDKOVÁ, Jitka ŘEHOŘOVÁ, Jana SMRŽOVÁ and Kateřina KAŇKOVÁ. Does genetic variability in the fructosamine-3-kinase play a role in the progression of diabetic nephropathy, morbidity and mortality of diabetics? In Diabetologia. 2010. ISSN 0012-186X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Does genetic variability in the fructosamine-3-kinase play a role in the progression of diabetic nephropathy, morbidity and mortality of diabetics?
Authors PÁCAL, Lukáš, Veronika TANHÄUSEROVÁ, Jan SVOJANOVSKÝ, Darja KRUSOVÁ, Soňa ŠTĚPÁNKOVÁ, Jindřich OLŠOVSKÝ, Jana BĚLOBRÁDKOVÁ, Jitka ŘEHOŘOVÁ, Jana SMRŽOVÁ and Kateřina KAŇKOVÁ.
Edition Diabetologia, 2010.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30202 Endocrinology and metabolism
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 6.973
Organization unit Faculty of Medicine
ISSN 0012-186X
UT WoS 000280689700318
Keywords in English fructosamine-3-kinase; polymorphism; diabetic nephropathy; mortality
Tags International impact, Reviewed
Changed by Changed by: Mgr. Lukáš Pácal, Ph.D., učo 14473. Changed: 20/4/2011 16:03.
Abstract
Fructosamines are products of non-enzymatic glycation formed in accelerated rate during hyperglycemia. As precursors of advanced glycation end-products (AGEs) fructosamines supposedly contribute to the development of glucotoxic injury. Mechanism of enzymatic deglycation of proteins in vivo by fructosamine-3-kinase (FN3K) was described recently. The -385A/G (rs3859206) and 900C/G (rs1056534) single nucleotide polymorphisms (SNPs) in the FN3K gene were found to have potential functional impact.The aim was to study relationship between polymorphisms in FN3K gene, progression of diabetic nephropathy (DN) and cardiovascular morbidity and mortality of diabetics. Based on our results, we can not identify high FN3K deglycating activity as a protective factor, on the contrary higher rate of 3-deoxyglucosone formation may counterbalance putative protection by providing substrate for Arg-directed glycation and AGE formation.
Links
NR9443, research and development projectName: Genetická variabilita enzymů pentózového cyklu jako faktor modulující nástup a progresi diabetické nefropatie
Investor: Ministry of Health of the CR, Genetic variability of pentose phosphate pathway as a modulating factor of the onset and progression of diabetic nephropathy
PrintDisplayed: 1/8/2024 00:24